Charlotte's Web Holdings Inc logo

CWEB - Charlotte's Web Holdings Inc News Story

C$6.1 0.0  0.7%

Last Trade - 15/01/21

Sector
Healthcare
Size
Mid Cap
Market Cap £490.1m
Enterprise Value £468.8m
Revenue £67.1m
Position in Universe 302nd / 2680

CANADA RESEARCH ROUNDUP-Centerra Gold, Medexus Pharmaceuticals, Savaria

Fri 27th March, 2020 7:43am
March 27 (Reuters) - Securities analysts revised their ratings and price targets on several
Canadian companies, including Centerra Gold, Medexus Pharmaceuticals and Savaria, on Friday. 
    
  HIGHLIGHTS
     * Centerra Gold Inc  CG.TO : Canaccord Genuity raises target price to C$13.50 from C$12
     * Medexus Pharmaceuticals  MDP.V : Canaccord Genuity cuts to speculative buy from buy
     * Savaria Corp  SIS.TO : Scotiabank cuts target price to C$14 from C$16.50
 
Following is a summary of research actions on Canadian companies reported by Reuters on Friday.
Stock entries are in alphabetical order.
     
     * Air Canada  AC.TO : National Bank of Canada cuts target price to C$30 from C$45
     * Centerra Gold Inc  CG.TO : Canaccord Genuity raises target price to C$13.50 from C$12
     * Charlotte'S Web Holdings Inc  CWEB.TO : Eight Capital cuts target price to C$9 from C$13
     * Mav Beauty Brands Inc  MAV.TO : CIBC cuts target price to C$3.50 from C$4.50
     * Medexus Pharmaceuticals  MDP.V : Canaccord Genuity cuts to speculative buy from buy
     * Medexus Pharmaceuticals  MDP.V : Canaccord Genuity cuts target price to C$5 from C$6.50
     * Saputo Inc  SAP.TO : National Bank of Canada cuts target price to C$40 from C$45
     * Saputo Inc  SAP.TO : Scotiabank cuts target price to C$42.50 from C$48.50
     * Savaria Corp  SIS.TO : National Bank of Canada raises target price to C$13 from C$12.50
     * Savaria Corp  SIS.TO : Scotiabank cuts target price to C$14 from C$16.50
    

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.